Bioc sec filings

Author: nwfj

August undefined, 2024

WebNov 14, 2024 · SAN DIEGO (November 10, 2024) – Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results … WebApr 11, 2024 · VitalStone Financial LLC purchased a new stake in Cisco Systems, Inc. ( NASDAQ:CSCO – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 864 shares of the network equipment provider’s stock, valued at …

Biocept Inc (BIOC) 8-K Earnings Release - Nov 2024

WebApr 6, 2024 · Biocept GAAP EPS of -$0.04 beats by $0.27, revenue of $5.59M misses by $2.27M SA NewsMon, Nov. 21, 2024 Biocept, Inc. SEC Filing - Quarterly Report (10-Q) November 21, 2024 SEC FilingsMon,... WebBiocept Inc. SEC filings breakout by MarketWatch. View the BIOC U.S. Securities and Exchange Commission reporting information. portland maine easter brunch 2022

VitalStone Financial LLC Takes $41,000 Position in Cisco Systems, …

WebApr 10, 2024 · UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of WebMay 12, 2024 · Ticker: BIOC CIK: 1044378 Form Type: 8-K Corporate News Accession Number: 0001564590-21-027005 Submitted to the SEC: Wed May 12 2024 4:14:46 PM … WebSEC Filings for Biocept Inc (BIOC) including Annual 10-K and Quarterly 10-Q Reports. optics11 pavone

BIOCEPT INC General Corporate Statement (Form8) - Biocept (NASDAQ:BIOC ...

SEC Filing Biocept Inc.

WebMar 20, 2024 · Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following … WebBiocept Inc. SEC filings breakout by MarketWatch. View the BIOC U.S. Securities and Exchange Commission reporting information. portland maine easter dinnerWebApr 13, 2024 · Millennium Management LLC purchased a new position in shares of Biocept, Inc. ( NASDAQ:BIOC – Get Rating) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 103,124 shares of the medical research company’s stock, valued at approximately $97,000. optics11 life

"WebApr 10, 2024 · SEC Filing Biocept Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 10, 2024 BIOCEPT, INC. (Exact name of registrant as … " - Bioc sec filings

Bioc sec filings

BIOC Biocept Inc. SEC Filings MarketWatch

WebJun 5, 2024 · On June 5, 2024, Biocept, Inc. (the “ Company ”) entered into a fifth amendment (the “ Amendment ”) to its lease agreement with ARE-SD Region No. … WebWe would like to show you a description here but the site won’t allow us.

Did you know?

WebApr 10, 2024 · Biocept Inc (BIOC) SEC Filing 8-K Material Event for the period ending Monday, April 10, 2024. Home. SEC Filings. Biocept Inc (BIOC) 8-K Material Event Mon … WebDec 31, 2024 · This Annual Report on Form 10-K, or Annual Report, contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as …

WebApr 10, 2024 · Biocept Inc (BIOC) SEC Filing 8-K Material Event for the period ending Monday, April 10, 2024. Home. SEC Filings. Biocept Inc (BIOC) 8-K Material Event Mon Apr 10 2024; SEC Filings. BIOC Valuations. Intrinsic Value. Financial Stability. Financial Ratios. Insider Trades. Manager Portfolios. Notifications. BIOC Annual Reports. 10-K … WebFind the latest Biocept, Inc. (BIOC) stock quote, history, news and other vital information to help you with your stock trading and investing.

WebApr 9, 2024 · SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K Current Report Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of … WebJun 15, 2024 · Last Updated: Corporate insiders are required to disclose purchases or sales of their own stock within two business days of when they occur. Using these disclosures, we collect data on insider trading activity, which can give hints on whether executives are bullish or bearish on their own companies. Search

WebApr 10, 2024 · united states securities and exchange commission washington, d.c. 20549 schedule 14a proxy statement pursuant to section 14(a) of the securities exchange act of 1934 ;

optics2WebApr 12, 2024 · The firm owned 175,500 shares of the medical research company’s stock after purchasing an additional 59,100 shares during the quarter. Renaissance Technologies LLC owned 1.04% of Biocept worth... optics4lifeWebFind the latest SEC Filings data for Biocept, Inc. Common Stock (BIOC) at Nasdaq.com. portland maine economyWebApr 5, 2024 · Biocept is filing a notification of late filing on Form 12b-25 with the Securities and Exchange Commission, which provides an automatic 15-day … optics4rentWebView 13F filing holders of Biocept Inc. 13F filings are submitted quarterly to the SEC by hedge funds and other investment managers. WhaleWisdom. 13F Data. Latest 13F … portland maine education lawyerWebMay 12, 2024 · SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of The Securities … optics4kidsWebNov 21, 2024 · Biocept Inc (BIOC) SEC Filing 8-K Material Event for the period ending Monday, November 21, 2024 optics4birding reviews